心筋梗塞後の二次予防における血圧管理

Massimo Volpe^1,2, Giovanna Gallo^1,3, Tomasz J Guzik^4,5

¹Clinical and Molecular Medicine Department, Sapienza University of Rome, Rome, Italy.

Cardiovascular research

|August 26, 2025

まとめ

急性心筋梗塞 (AMI) の後の血圧管理は議論されている. このレビューでは,血圧目標と J 形現象の証拠を,AMI後の二次予防で検討しています.

科学分野:

心臓病科
心血管医学
内科医学

背景:

急性心筋梗塞 (AMI) の後の血圧 (BP) の管理には,特定の試験データとガイドラインの焦点が欠けている.
二次予防では,再発性心血管疾患は血圧制御によって影響を受けます.
低静脈血圧 (DBP) がAMI後のリスクを増加させるというJ形現象については不確実性があります.

研究の目的:

AMI後の二次予防のためのBP制御に関する現在の証拠をレビューする.
AMI後のJ形現象に関する議論を進めること.

主な方法:

既存の科学文献と臨床ガイドラインのレビュー
血圧目標と心血管疾患リスクに関する証拠の分析
急性心筋梗塞の文脈におけるJ型結合の検討

主要な成果:

予期的なデータでは,AMI後の患者の正確なBP目標値が定義されていません.
国際的なガイドラインは,AMI BP後の管理に関する限られたガイドラインを提供します.
静脈圧に対する J 形現象の影響は不明である.

結論:

AMI後の証拠に基づいたBP目標を確立するには,さらなる研究が必要です.
BP,特にDBPの過剰な低下の潜在的なリスクは慎重に検討する必要があります.
急性心筋梗塞後の二次予防には BP管理を最適化することが重要です.

キーワード:

J曲線現象について急性冠動脈症候群血圧管理冠動脈疾患二次予防

さらに関連する動画

09:00

Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke

Published on: February 10, 2023

1.3K

14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.6K

関連する概念動画

01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.

01:18

Hypertension and Regulation of Blood Pressure

3.1K

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...

3.1K

01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

01:25

Errors occurring during blood pressure monitoring

965

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...

965

01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

関連する実験動画